MENÚ
AR | ARS
-
-
-
-
- Advanced Therapies Week (ATW) 2025
- Forum Labo 2025
- SLAS Europe 2025
- Bioprocessing Summit Europe 2025
- Medlab Middle East 2025
- SLAS International 2025
- Biologics World Nordics 2025
- ASIA LABEX: The Lab Show 2025
- BioProcess International Europe 2025
- ISEV 2025
- Future Labs Live 2025
- Cell 2025
- ASIA LABEX: The Lab Show 2025
- Stem Cell Community Day 2025
-
-
-
-
- Advanced Therapies Week (ATW) 2025
- Forum Labo 2025
- SLAS Europe 2025
- Bioprocessing Summit Europe 2025
- Medlab Middle East 2025
- SLAS International 2025
- Biologics World Nordics 2025
- ASIA LABEX: The Lab Show 2025
- BioProcess International Europe 2025
- ISEV 2025
- Future Labs Live 2025
- Cell 2025
- ASIA LABEX: The Lab Show 2025
- Stem Cell Community Day 2025
AR | ARS
-
- Pipeteo manual & dispensación
- Pipetas mecánicas
- Pipetas electrónicas
- Pipetas multicanal
- Pipetas de desplazamiento positivo y dispensadores
- Pipeteo automatizado
- Dispensadores de botella
- Controladores de pipeta
- Puntas de pipeta
- Consumibles de automatización
- Accesorios para dispensadores y pipetas
- Accesorios de automatización
- Servicios para dispensadores y pipetas
Está a punto de abandonar este sitio.
Por favor, tenga en cuenta que su carro de la compra actual no ha sido guardado todavía y no podrá ser restablecido en el nuevo sitio ni cuando regrese. Si desea guardar su carro de la compra, inicie sesión en su cuenta.
Sorry, we couldn't find anything on our website containing your search term.
CAR-T Cell Research and Development
Well thought-out tools for pharmaceutical and biotech laboratories
Read more
Read less
Product Solutions for the CAR-T Cell Research Workflow
CAR-T cells, genetically engineered and equipped with specific receptors to target and combat cancer cells, are primarily divided into two categories: autologous and allogenic CAR-T cells. Hereby, autologous CAR-T cells derive from the patient’s own white blood cells and are reintroduced after modification, whereas allogenic CAR-T cells are designed as off-the-shelf solutions for use in different patients. However, both approaches have their challenges. The manufacturing process for autologous CAR-T cells is complex and costly, as each patient’s cells must be individually processed. Allogeneic CAR-T cells, on the other hand, currently do not have the same safety profile, necessitating further research to address these issues.
Leer más
Leer menos
ADVANCING CAR-T CELL RESEARCH: FROM PBMC ISOLATION TO LARGE-SCALE PRODUCTION
Leer más
Leer menos

*All products are for Research Use Only (RUO).
Leer más
Leer menos